http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1777827

Outgoing Links

Predicate Object
contentType Case Reports|English Abstract|Journal Article|Research Support, U.S. Gov't, Non-P.H.S.
endingPage 21
issn 1009-2137
issueIdentifier 5
pageRange 1117-21
publicationName Zhongguo shi yan xue ye xue za zhi
startingPage 1117
bibliographicCitation Li SX, Zhu HL, Guo B, Lu XC, Fan H, Lin J, Yang B, Liu Y, Yang Y, Ran HH, Zhai B, Han WD, Wang Y, Yao SQ. [Curative efficiency of rituximab combined with autologous cytokine induced killer cells on aged patient with orbital diffuse large B cell lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Oct;20(5):1117–21. PMID: 23114130.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_892f25429ad51282805a84c5bfec081f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70dbcceb6fffdc8668dd6dca9cb46e29
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42625018358f4b2c62a9e96e6f56abc1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb86588a2f87823a501319621dcd0a04
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9cd7cb81dcb6192118ca71f8183680a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7dc34f855491afedab70649276f044af
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd4f9b3afc26b058001afc5cd2b388fc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3450973665ff552a712cde370cd48fe4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_828240707086884afe4e220e8e6f92cf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46cfac20274019943a08b029941089e8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93a9cb51adf8f06028196030242ad897
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3bcb3758fe424bfcf5ab7780a32ca77d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_85ffd7a6fdd0cd08c903173279cba502
date 201210
identifier https://pubmed.ncbi.nlm.nih.gov/23114130
isPartOf https://portal.issn.org/resource/ISSN/1009-2137
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30140
language Chinese
source https://pubmed.ncbi.nlm.nih.gov/
title [Curative efficiency of rituximab combined with autologous cytokine induced killer cells on aged patient with orbital diffuse large B cell lymphoma]
discusses http://id.nlm.nih.gov/mesh/M0544940
http://id.nlm.nih.gov/mesh/M0244307
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D009918Q000628
http://id.nlm.nih.gov/mesh/D055612Q000637
http://id.nlm.nih.gov/mesh/D016403Q000628
http://id.nlm.nih.gov/mesh/D058846Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D003131
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D055612Q000166
http://id.nlm.nih.gov/mesh/D000069283
http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID1718
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_375c17477d468e8296a40307695528e6
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_118dd6abf266102dccb53d8fc658affb
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9859

Total number of triples: 46.